Ningbo Newbay Technology Development Co., Ltd

This early-stage study tested a new drug called NB003 in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals were to find a safe dose, see how the body processes the drug, and check for any early signs that it might help shrink tu…